Johnson & Johnson scores Darzalex convenience boost with OK for speedy new formulation

1st May 2020 Uncategorised 0

Johnson & Johnson is ready to take treatment time for multiple myeloma patients down from hours to just minutes with its new formulation of blockbuster Darzalex, and the drug’s latest FDA approval couldn’t come at a more opportune time for the New Jersey drugmaker.

More: Johnson & Johnson scores Darzalex convenience boost with OK for speedy new formulation
Source: fierce